Dr. Foods, Inc. (DRFS) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
3F K MINAMIAOYAMA TOKYO, 107-0062 |
| State of Incorp. | NV |
| Fiscal Year End | March 31 |
| Industry (SIC) | 677 - Blank Checks (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 12/31/2023 MRQ | 3/31/2023 | 3/31/2022 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 1,365 | ||||
| Cash and cash equivalents | 1,365 | ||||
| Receivables | 384 | ||||
| Advances on inventory purchases | 567 | ||||
| Other undisclosed current assets | 539,862 | ||||
| Total current assets: | 542,178 | ||||
| Noncurrent Assets | |||||
| Deferred income tax assets | 288,684 | ||||
| Other undisclosed noncurrent assets | (288,684) | ||||
| TOTAL ASSETS: | 542,178 | ||||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,101 | 7,000 | |||
| Accounts payable | 7,396 | ||||
| Accrued liabilities | 2,705 | 7,000 | |||
| Other liabilities | 497 | ||||
| Due to related parties | ✕ | 29,524 | |||
| Total current liabilities: | 40,122 | 7,000 | |||
| Noncurrent Liabilities | |||||
| Other undisclosed liabilities | |||||
| Total liabilities: | 40,122 | 7,000 | |||
| Equity | |||||
| Equity, attributable to parent, including: | 502,056 | (7,000) | |||
| Preferred stock | 1 | 1 | |||
| Common stock | 1,312 | 231,528 | |||
| Additional paid in capital | 1,899,114 | 814,339 | |||
| Accumulated deficit | (1,374,688) | (1,052,868) | |||
| Other undisclosed equity, attributable to parent | (23,683) | ||||
| Total equity: | 502,056 | (7,000) | |||
| TOTAL LIABILITIES AND EQUITY: | 542,178 | ||||
Income Statement (P&L) (USD)
| 12/31/2023 TTM | 3/31/2023 | 3/31/2022 | ||
|---|---|---|---|---|
| Revenues | 1,000 | |||
| Other undisclosed gross profit | 38 | |||
| Gross profit: | 1,038 | |||
| Operating expenses | (326,423) | (1,047,108) | ||
| Operating loss: | (325,385) | (1,047,108) | ||
| Loss from continuing operations before income taxes: | (325,385) | (1,047,108) | ||
| Income tax expense (benefit) | 774 | |||
| Loss from continuing operations: | (324,611) | (1,047,108) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (1,047,108) | |
| Net loss: | (324,611) | (1,047,108) | ||
| Other undisclosed net income attributable to parent | 2,791 | |||
| Net loss available to common stockholders, diluted: | (321,820) | (1,047,108) | ||
Comprehensive Income (USD)
| 12/31/2023 TTM | 3/31/2023 | 3/31/2022 | ||
|---|---|---|---|---|
| Net loss: | (324,611) | (1,047,108) | ||
| Comprehensive loss, net of tax, attributable to parent: | (324,611) | (1,047,108) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.